ClassID:

108997

C12N9/96 - page 4 - CPC Classification

Classification description:

Enzymes; Proenzymes; Compositions thereof ; Processes for preparing, activating, inhibiting, separating or purifying enzymes Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates

Recent Application in this class:
#901
20150044731
2015-02-12

Psychrophilic enzymes compositions and methods for making and using same

#902
20150044194
2015-02-12

High concentration alpha-glucosidase compositions for the treatment of Pompe disease

#903
20150044189
2015-02-12

Hybrid polymers, pharmaceutical compositions and methods of synthesizing the same

#904
20150037871
2015-02-05

Therapeutic nuclease compositions and methods

#905
20150037491
2015-02-05

Phytic Acid as a Stabilizer for Phytase

#906
20150031748
2015-01-29

Modulating the interaction between ZO-2/TJP2 and a Snail zinc finger transcription factor family member

#907
20150031106
2015-01-29

HCV PROTEASE INHIBITORS AND USES THEREOF

#908
20150031020
2015-01-29

Enzyme-pore constructs

#909
20150024485
2015-01-22

Puro-DHFR quadrifunctional marker and its use in protein production

#910
20150023987
2015-01-22

Immunogenic compositions and reagents for preparing

#911
20150010982
2015-01-08

Methods and compositions for generating bioactive assemblies of increased complexity and uses

#912
20150010947
2015-01-08

Domain Swapping Modules

#913
20150010944
2015-01-08

Modified SAK gene for the production of recombinant proteins

#914
20150010522
2015-01-08

Human arginase and site-directed pegylated human arginase and the use thereof

#915
20150004667
2015-01-01

Functionalized graphene substrates

#916
20140377859
2014-12-25

NPP1 fusion proteins

#917
20140370553
2014-12-18

Enzymes for starch processing

#918
20140370016
2014-12-18

SPARC binding ScFcs

#919
20140363417
2014-12-11

Human arginase and pegylated human arginase and the use thereof

#920
20140363415
2014-12-11

Compositions and methods comprising glycyl-tRNA synthetases having non-canonical biological activities

#921
20140356384
2014-12-04

Erythrocyte-binding therapeutics

#922
20140349369
2014-11-27

Histidyl-tRNA synthetase-Fc conjugates

#923
20140341905
2014-11-20

SPARC binding ScFcs

#924
20140341904
2014-11-20

SPARC binding ScFvs

#925
20140335573
2014-11-13

Fusion proteins comprising type-II cohesin modules, multi-enzyme complexes comprising same and uses thereof

#926
20140335163
2014-11-13

TARGETED IDURONATE-2-SULFATASE COMPOUNDS

#927
20140329994
2014-11-06

Branched polymers

#928
20140322791
2014-10-30

Process to prepare a stable thrombin composition

#929
20140322788
2014-10-30

Method for increasing protein thermal stability

#930
20140322762
2014-10-30

Treatment of cellulosic material and enzymes useful therein

#931
20140322132
2014-10-30

Fragments of p97 and uses thereof

#932
20140316137
2014-10-23

Coelenterazine analogues and coelenteramide analogues

#933
20140315185
2014-10-23

METHODS AND COMPOSITIONS FOR IMPROVING SPERM FUNCTIONALITY

#934
20140308690
2014-10-16

Devices containing dried reagents for reconstitution as calibration and/or quality control solutions, and methods of production and use thereof

#935
20140308342
2014-10-16

REPROGRAMMING UROKINASE INTO AN ANTIBODY-RECRUITING ANTICANCER AGENT

#936
20140302582
2014-10-09

Engineered E2 For Increasing The Content Of Free LYS11-Linked Ubiquitin

#937
20140302001
2014-10-09

Methods for coupling targeting peptides onto recombinant lysosomal enzymes for improved treatments of lysosomal storage diseases

#938
20140295557
2014-10-02

Using truncated guide RNAs (tru-gRNAs) to increase specificity for RNA-guided genome editing

#939
20140295556
2014-10-02

Using RNA-guided FokI nucleases (RFNs) to increase specificity for RNA-guided genome editing

#940
20140294767
2014-10-02

Method of treating HCV infection with a small molecule CHK2 inhibitor

#941
20140294757
2014-10-02

Stabilisation of polypeptides

#942
20140287484
2014-09-25

Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations thereof

#943
20140273155
2014-09-18

COMPOSITION AND METHOD FOR PRODUCING SAME

#944
20140273153
2014-09-18

Covalent modification of biological macromolecules

#945
20140273151
2014-09-18

ENZYME SUBSTRATE COMPRISING A FUNCTIONAL DYE AND ASSOCIATED TECHNOLOGY AND METHODS

#946
20140273142
2014-09-18

Nanolipoprotein particles comprising a natural rubber biosynthetic enzyme complex and related products, methods and systems

#947
20140255376
2014-09-11

Regulation of specific spinal neurons regulating pain transmission via chimeric toxins

#948
20140255375
2014-09-11

Thrombopoietic activity of tyrosyl-tRNA synthetase polypeptides

#949
20140250942
2014-09-11

STABLE SOLUTIONS OF SACROSIDASE

#950
20140242057
2014-08-28

Conjugated factor VIII molecules

#951
20140242056
2014-08-28

Preparation of stabilized catalase enzymes using polyvinyl alcohol

#952
20140227787
2014-08-14

CRISPR-Cas systems and methods for altering expression of gene products

#953
20140221290
2014-08-07

Stabilizing agent for pharmaceutical proteins

#954
20140212403
2014-07-31

Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria

#955
20140199749
2014-07-17

Compositions and Methods for cDNA Synthesis

#956
20140193890
2014-07-10

Thermostable enzymes and methods of making and using the same

#957
20140193390
2014-07-10

High concentration α-glucosidase compositions for the treatment of Pompe disease

#958
20140186868
2014-07-03

Method for adapting a hydrolytic enzyme to a component that stabilizes the hydrolytic enzyme

#959
20140186323
2014-07-03

FACTOR VIIA-POLYSIALIC ACID CONJUGATES HAVING PROLONGED IN VIVO HALF-LIFE

#960
20140178962
2014-06-26

ENGINEERED CARBONIC ANHYDRASE PROTEINS FOR CO2 SCRUBBING APPLICATIONS

#961
20140170753
2014-06-19

CRISPR-Cas systems and methods for altering expression of gene products

#962
20140170729
2014-06-19

Sso7-polymerase conjugates with decreased non-specific activity

#963
20140170728
2014-06-19

Factor IX: Remodeling and Glycoconjugation of Factor IX

#964
20140170129
2014-06-19

Preparation of stabilized catalase enzymes with a surfactant

#965
20140154776
2014-06-05

Stable lysis buffer mixture for extracting nucleic acids

#966
20140154775
2014-06-05

Photocleavable linker

#967
20140154774
2014-06-05

NPP1 FUSION PROTEINS

#968
20140154773
2014-06-05

Thrombin solution and methods of use thereof

#969
20140147429
2014-05-29

Therapeutic fusion proteins

#970
20140141486
2014-05-22

Activated sialic acid derivatives for protein derivatisation and conjugation

#971
20140141483
2014-05-22

Polymer factor IX moiety conjugates

#972
20140134702
2014-05-15

Solubilized Phospholipids for Stabilizing Nucleic Acid Polymerases

#973
20140127778
2014-05-08

Manufacturing method for silica encapsulated single-enzyme nanoparticles and single-enzyme nanoparticles manufactured by means of method

#974
20140127777
2014-05-08

METHOD FOR STABILIZATION OF PROTEINS USING NON-NATURAL AMINO ACIDS

#975
20140127771
2014-05-08

Methods of increasing the cellulolytic enhancing activity of a polypeptide

#976
20140127753
2014-05-08

Enzymes for starch processing

#977
20140120538
2014-05-01

Coelenterazine analogues and coelenteramide analogues

#978
20140120123
2014-05-01

Fusion proteins for the treatment of allergic diseases

#979
20140113349
2014-04-24

Solubilized phospholipids for stabilizing nucleic acid polymerases

#980
20140106433
2014-04-17

RNase H-based assays utilizing modified RNA monomers

#981
20140106409
2014-04-17

Chimeric alpha-amylase variants

#982
20140099697
2014-04-10

Method for preventing the unfolding of a (poly)peptide and/or inducing the (re-)folding of a (poly)peptide

#983
20140099294
2014-04-10

Biotherapy for pain

#984
20140093935
2014-04-03

Charged triplet-state quenchers for mitigation of photo-induced damage

#985
20140087418
2014-03-27

Organic-inorganic nanoflowers, their synthesis and use

#986
20140065123
2014-03-06

Pegylated analogue protein or canine urate oxidase, preparation method and use thereof

#987
20140050666
2014-02-20

Scavenger receptor uptake for fabry disease enzyme replacement therapy

#988
20140045241
2014-02-13

MICELLAR POLYSILOXANE ENZYME IMMOBILIZATION MATERIALS

#989
20140038269
2014-02-06

Method for producing dry microbial cell powder

#990
20140038261
2014-02-06

Compositions and methods of use of immunotoxins comprising ranpirnase (Rap) show potent cytotoxic activity

#991
20140038237
2014-02-06

Nucleic acid modifying enzymes

#992
20140030278
2014-01-30

Conjugates of tumor necrosis factor inhibitors to functionalized polymers

#993
20140010798
2014-01-09

Treatment with factor ix-albumin fusion protein

#994
20140004592
2014-01-02

Dendrimer-based excipients for the attenuation of protein aggregation

#995
20140004591
2014-01-02

Site specifically incorporated initiator for growth of polymers from proteins

#996
20140004581
2014-01-02

IMMOBILIZED INTERFACIAL ENZYMES OF IMPROVED AND STABILIZED ACTIVITY

#997
20140004095
2014-01-02

Treatment with factor VII-albumin fusion protein

#998
20130345099
2013-12-26

Nano-encapsulated triggered-release viscosity breaker

#999
20130344099
2013-12-26

Fusion protein for secretory protein expression

#1000
20130344052
2013-12-26

PEG-modified arginine/lysine oxidoreductase

#1001
20130337537
2013-12-19

COAGULATION FACTOR-TARGETING TO TLT-1 ON ACTIVATED PLATELETS

#1002
20130337535
2013-12-19

Control of Cyanate in Aqueous Urea Solutions by Non-1,2-Ethylene Diamine Like Compounds for the Protection of Protein/Peptide Carbamylation

#1003
20130323222
2013-12-05

HUMAN TISSUE KALLIKREIN 1 GLYCOSYLATION ISOFORMS

#1004
20130309747
2013-11-21

MGMT-based method for obtaining high yields of recombinant protein expression

#1005
20130296258
2013-11-07

Muteins of human lipocalin 2 with affinity for glypican-3 (GPC-3)

#1006
20130295643
2013-11-07

Non-cytotoxic protein conjugates

#1007
20130295642
2013-11-07

Protein complex having activity catalyzing asymmetric oxidation reaction and process for producing the same

#1008
20130295639
2013-11-07

Branched polymers

#1009
20130295638
2013-11-07

Synthetic -derived chloroplast transit peptides

#1010
20130295626
2013-11-07

Protein complex having activity catalyzing asymmetric oxidation reaction and process for producing the same

#1011
20130295072
2013-11-07

Long-acting coagulation factors and methods of producing same

#1012
20130295004
2013-11-07

IL-1 BINDING PROTEINS

#1013
20130288314
2013-10-31

Protective structure of substance to be protected, method of protecting substance to be protected, enzymatic reaction method, method of producing reaction product, method for adjusting the speed of enzymatic reaction, and enzyme material use kit

#1014
20130287755
2013-10-31

Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl-tRNA synthetases

#1015
20130280782
2013-10-24

Protein-based conjugates and self-assembled nanostructures

#1016
20130274147
2013-10-17

Integrated sample preparation systems and stabilized enzyme mixtures

#1017
20130273628
2013-10-17

Hydrogenase fusion protein for improved hydrogen production

#1018
20130273531
2013-10-17

AMBIENT TEMPERATURE STABLE KITS FOR MOLECULAR DIAGNOSTICS

#1019
20130273021
2013-10-17

NPP1 fusion proteins

#1020
20130272966
2013-10-17

RET2IR CONJUGATES, RET2IR CONJUGATE SYSTEMS AND METHODS OF USE THEREOF

#1021
20130266553
2013-10-10

Albumin Fusion Proteins

#1022
20130260407
2013-10-03

METHOD FOR THE PURIFICATION AND STABILISATION OF ENZYME GLUCONATE DEHYDROGENASE (GADH, EC 1.1.99.3), ENZYME GLUCONATE DEHYDROGENASE (GADH, EC 1.1.99.3), AND THE USE OF ENZYME GLUCONATE DEHYDROGENASE (GADH, EC 1.1.99.3)

#1023
20130252287
2013-09-26

Protein-enhanced surfactants for enzyme activation

#1024
20130244301
2013-09-19

Dynamic thermoresponsive nanoparticles for stabilization of enzymes at high temperatures

#1025
20130243765
2013-09-19

CHIMERIC PROTEIN

#1026
20130243745
2013-09-19

Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Lysyl-tRNA synthetases

#1027
20130236486
2013-09-12

IMMUNOGENIC VACCINE

#1028
20130236455
2013-09-12

Compositions and methods comprising glycyl-tRNA synthetases having non-canonical biological activities

#1029
20130236440
2013-09-12

Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-tRNA synthetases

#1030
20130232589
2013-09-05

Ovr110 antibody compositions and methods of use

#1031
20130231268
2013-09-05

Stabilized acid precursor and acid-enzyme formulations for drilling mud cake removal

#1032
20130230507
2013-09-05

Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-tRNA synthetase complex

#1033
20130230504
2013-09-05

Pharmaceutical compositions comprising peptide antagonists of vascular endothelial growth factor

#1034
20130230483
2013-09-05

Fusion molecule based on novel TAA variant

#1035
20130224828
2013-08-29

RNA-Directed Packaging of Enzymes Within Protein Particles

#1036
20130224827
2013-08-29

ENDOTHELIAL NITRIC OXIDE SYNTHASE

#1037
20130224801
2013-08-29

Treatment of cellulosic material and enzymes useful therein

#1038
20130224212
2013-08-29

METHODS AND PRODUCTS RELATING TO GSK3SS REGULATION

#1039
20130224174
2013-08-29

Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases

#1040
20130219552
2013-08-22

Glyphosate resistant plants and associated methods

#1041
20130217577
2013-08-22

Class of glyphosate resistance genes

#1042
20130217077
2013-08-22

Compositions comprising a polypeptide having cellulolytic enhancing activity and a bicycle compound and uses thereof

#1043
20130216513
2013-08-22

Chimeric Clotting Factors

#1044
20130212737
2013-08-15

Glyphosate resistant plants and associated methods

#1045
20130211055
2013-08-15

Dithioamine reducing agents

#1046
20130210117
2013-08-15

CRYSTALS OF MEMBRANE PROTEINS

#1047
20130210115
2013-08-15

Method for activating catalyst using photothermal nanomaterials

#1048
20130210114
2013-08-15

Synthetic chloroplast transit peptides

#1049
20130209472
2013-08-15

Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Asparaginyl tRNA synthetases

#1050
20130205441
2013-08-08

Chloroplast transit peptide

#1051
20130205440
2013-08-08

Synthetic brassica-derived chloroplast transit peptides

#1052
20130203148
2013-08-08

Modified clostridial toxins with enhanced translocation capability and enhanced targeting activity

#1053
20130203119
2013-08-08

Nucleic acid modifying enzymes

#1054
20130203111
2013-08-08

Aldehyde tags, uses thereof in site-specific protein modification

#1055
20130202596
2013-08-08

Processable single chain molecules and polypeptides made using same

#1056
20130202595
2013-08-08

Factor IX polypeptides and methods of use thereof

#1057
20130202576
2013-08-08

INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF HISTIDYL-TRNA SYNTHETASES

#1058
20130202575
2013-08-08

Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-tRNA synthetases

#1059
20130202574
2013-08-08

Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Valyl-tRNA synthetases

#1060
20130196407
2013-08-01

Non-leachable magnetic cross-linked enzyme aggregate

#1061
20130196406
2013-08-01

NOVEL PROTEIN-POLYMER NANOCAPSULES

#1062
20130195832
2013-08-01

Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases

#1063
20130195829
2013-08-01

Themostable Phytase Variants

#1064
20130189756
2013-07-25

Chemically modified carbonic anhydrases useful in carbon capture systems

#1065
20130189747
2013-07-25

Compositions Comprising A Polypeptide Having Cellulolytic Enhancing Activity And A Sulfur-Containing Compound And Uses Thereof

#1066
20130189745
2013-07-25

ARTIFICIAL CELLULOSOME AND THE USE OF THE SAME FOR ENZYMATIC BREAKDOWN OF RESILIENT SUBSTRATES

#1067
20130189239
2013-07-25

Conjugated Factor VIII Molecules

#1068
20130189238
2013-07-25

Fusion proteins

#1069
20130189197
2013-07-25

LONG-CHAIN OXYAMINOPOLYOL BASED GELATOR AND GEL

#1070
20130184334
2013-07-18

THERAPEUTIC NUCLEASE COMPOSITIONS AND METHODS

#1071
20130183722
2013-07-18

Compositions comprising a polypeptide having cellulolytic enhancing activity and a nitrogen-containing compound and uses thereof

#1072
20130183712
2013-07-18

Method and compositions for the detection of protein glycosylation

#1073
20130183368
2013-07-18

P97-antibody conjugates and methods of use

#1074
20130183308
2013-07-18

THERAPEUTIC NUCLEASE COMPOSITIONS AND METHODS

#1075
20130183280
2013-07-18

STABILIZED FACTOR VIII VARIANTS

#1076
20130177983
2013-07-11

Methods and compositions for regulation of transgene expression

#1077
20130177961
2013-07-11

Multi-armed, monofunctional, and hydrolytically stable derivatives of poly(ethylene glycol) and related polymers for modification of surfaces and molecules

#1078
20130177960
2013-07-11

Methods and compositions for regulation of transgene expression

#1079
20130177959
2013-07-11

NOVEL CBH1-EG1 FUSION PROTEINS AND USE THEREOF

#1080
20130172705
2013-07-04

ENZYME CO-FACTOR ENHANCEMENT OF BIOSENSOR PERFORMANCE

#1081
20130171714
2013-07-04

Puro-DHFR quadrifunctional marker and its use in protein production

#1082
20130171660
2013-07-04

BLOOD MARKER FOR RENAL CANCER

#1083
20130171175
2013-07-04

Factor IX polypeptides and methods of use thereof

#1084
20130171138
2013-07-04

Immunoglobulin chimeric monomer-dimer hybrids

#1085
20130164817
2013-06-27

Polypeptides having nucleic acid binding activity

#1086
20130164816
2013-06-27

Methods and compositions for generating bioactive assemblies of increased complexity and uses

#1087
20130164815
2013-06-27

PROCESS FOR THE PRODUCTION OF A REVERSIBLY INACTIVE ACIDIFIED PLASMIN COMPOSITION

#1088
20130164791
2013-06-27

Compositions comprising a polypeptide having cellulolytic enhancing activity and a quinone compound and uses thereof

#1089
20130164310
2013-06-27

Anti-diabetic compounds

#1090
20130164288
2013-06-27

READTHROUGH ACETYLCHOLINESTERASE (ACHE-R) FOR TREATING OR PREVENTING PARKINSON'S DISEASE

#1091
20130164273
2013-06-27

Reversibly inactivated acidified plasmin composition

#1092
20130157339
2013-06-20

Stabilized protease composition

#1093
20130157317
2013-06-20

Compositions comprising a polypeptide having cellulolytic enhancing activity and a dioxy compound and uses thereof

#1094
20130157314
2013-06-20

Compositions comprising a polypeptide having cellulolytic enhancing activity and a heterocyclic compound and uses thereof

#1095
20130156747
2013-06-20

PEGylated mutated clostridium botulinum toxin

#1096
20130156723
2013-06-20

Synthetic stereoisomer peptides in the retro-inverso and inverso configuration, and with cyclic and linear structure, their polymer conjugates, their encapsulation in polymer particles, and uses thereof

#1097
20130156693
2013-06-20

Anti-TAT226 antibodies and immunoconjugates

#1098
20130149698
2013-06-13

STABLE COMPOSITIONS FOR NUCLEIC ACID AMPLIFICATION AND SEQUENCING

#1099
20130143951
2013-06-06

Humanized TTC and methods of use thereof

#1100
20130143297
2013-06-06

STABILIZED LIQUID TENSIDE PREPARATION COMPRISING ENZYMES

#1101
20130143295
2013-06-06

Amylases and glucoamylases, nucleic acids encoding them and methods for making and using them

#1102
20130139477
2013-06-06

Method of providing a chemical or biological material in quantised form and system therefor

#1103
20130137157
2013-05-30

GLYCOPEGYLATED FACTOR VII AND FACTOR VIIA

#1104
20130137104
2013-05-30

Methods and compositions for modification of the HPRT locus

#1105
20130130347
2013-05-23

Constructs and methods for the assembly of biological pathways

#1106
20130129698
2013-05-23

Conjugated blood coagulation factor VIIa

#1107
20130122591
2013-05-16

Methods and compositions for modification of the locus

#1108
20130122565
2013-05-16

Induction and stabilization of enzymatic activity in microorganisms

#1109
20130122542
2013-05-16

Modified SAK gene for the production of recombinant proteins

#1110
20130116280
2013-05-09

Fusion protein comprising C-terminal domain of RET protein and use thereof as a diagnosing marker

#1111
20130109737
2013-05-02

MEDIATOR AND COHESIN CONNECT GENE EXPRESSION AND CHROMATIN ARCHITECTURE

#1112
20130109073
2013-05-02

Modular method to prepare tetrameric cytokines with improved pharmacokinetics by the dock-and-lock

#1113
20130109034
2013-05-02

Compositions and Methods for Determining Celiac Disease

#1114
20130108635
2013-05-02

Methods, compositions, and kits for the treatment of matrix mineralization disorders

#1115
20130108606
2013-05-02

Albumin fusion proteins

#1116
20130101611
2013-04-25

CITRULLINATION OF HUMAN PEPTIDYLARGININE DEIMINASE 4 (PAD-4) REGULATES ITS FUNCTION AND IMMUNOGENICITY

#1117
20130095547
2013-04-18

METHOD FOR SELECTIVE CONJUGATION OF ANALYTES TO ENZYMES WITHOUT UNWANTED ENZYME-ENZYME CROSS-LINKING

#1118
20130095090
2013-04-18

FACTOR VIIA COMPLEX USING AN IMMUNOGLOBULIN FRAGMENT

#1119
20130089895
2013-04-11

Polypeptides having nucleic acid binding activity and compositions and methods for nucleic acid amplification

#1120
20130079246
2013-03-28

Methods and Tools for Screening Agents Exhibiting an Activity on Receptors of the Tumor Necrosis Factor Receptor Superfamily

#1121
20130071431
2013-03-21

Method for Preserving Polypeptides Using A Sugar and Polyethyleneimine

#1122
20130065291
2013-03-14

Coatings containing polymer modified enzyme for stable self-cleaning of organic stains

#1123
20130065273
2013-03-14

Engineered E2 for increasing the content of free LYS11-linked ubiquitin

#1124
20130052677
2013-02-28

PEG-urate oxidase conjugates and use thereof

#1125
20130052663
2013-02-28

Chimeric Receptors and Methods for Identifying Agents Exhibiting an Activity on Type 1 Single Pass Transmembrane Receptors

#1126
20130045522
2013-02-21

MULTIFUNCTIONAL ZWITTERIONIC POLYMER CONJUGATES

#1127
20130040363
2013-02-14

Labeled enzyme compositions, methods and systems

#1128
20130035232
2013-02-07

INDUCTION AND STABILIZATION OF ENZYMATIC ACTIVITY IN MICROORGANISMS

#1129
20130034877
2013-02-07

Method for increasing thermal stability and retaining activity of a protein

#1130
20130034532
2013-02-07

Nanozymes, methods of making nanozymes, and methods of using nanozymes

#1131
20130034517
2013-02-07

Targeted drug phosphorylcholine polymer conjugates

#1132
20130029384
2013-01-31

THERMOSTABLE SUCROSE PHOSPHORYLASE

#1133
20130017991
2013-01-17

HCV protease inhibitors and uses thereof

#1134
20130012690
2013-01-10

METHOD FOR STABILIZATION OF PROTEINS USING NON-NATURAL AMINO ACIDS

#1135
20120329100
2012-12-27

Lignin-based enzyme stabilizer

#1136
20120329042
2012-12-27

Methods and apparatus for single molecule sequencing using energy transfer detection

#1137
20120322134
2012-12-20

Branched polymers

#1138
20120322057
2012-12-20

POLYMERASE COMPOSITIONS AND METHODS

#1139
20120308987
2012-12-06

Matrices and media for storage and stabilization of biomolecules

#1140
20120282669
2012-11-08

Solubilized phospholipids for stabilizing nucleic acid polymerases

#1141
20120276565
2012-11-01

Stabilization of enzymes with stable coenzymes

#1142
20120258460
2012-10-11

SSO7-polymerase conjugates with decreased non-specific activity

#1143
20120252732
2012-10-04

ALBUMIN FUSION PROTEINS

#1144
20120246757
2012-09-27

MODULATION OF CELLULAR PROTEIN FUNCTION BY ARTIFICIAL SUMO LIGASES

#1145
20120244598
2012-09-27

Stabilization of thermolysin in aqueous solution

#1146
20120237514
2012-09-20

VASCULAR ENDOTHELIAL CELL GROWTH FACTOR ANTAGONISTS AND USES THEREOF

#1147
20120232014
2012-09-13

Antithrombotic compounds

#1148
20120225066
2012-09-06

Therapeutic nuclease compositions and methods

#1149
20120220517
2012-08-30

Glycopegylation methods and proteins/peptides produced by the methods

#1150
20120220025
2012-08-30

PROCESS FOR ACCELERATED CAPTURE OF CARBON DIOXIDE

#1151
20120214220
2012-08-23

Xylanase composition with increased stability

#1152
20120213809
2012-08-23

Vault complexes for cytokine delivery

#1153
20120207735
2012-08-16

Non-cytotoxic protein conjugates

#1154
20120178139
2012-07-12

Erythrocyte-binding therapeutics

#1155
20120178138
2012-07-12

Modifications of peptide compositions to increase stability and delivery efficiency

#1156
20120177625
2012-07-12

CHEMICALLY MODIFIED FACTOR IX

#1157
20120171736
2012-07-05

POWDERY LIPASE PREPARATION AND USE THEREOF

#1158
20120164708
2012-06-28

STABILIZED ENZYME COMPOSITIONS

#1159
20120149843
2012-06-14

Nanofibers and morphology shifting micelles

#1160
20120149083
2012-06-14

PEG-Urate Oxidase Conjugates and Use Thereof

#1161
20120149082
2012-06-14

Method for preparing hybrid cross-linked enzyme-silica aggregates

#1162
20120142070
2012-06-07

Rehydratable matrices for dry storage of TAQ polymerase in a microfluidic device

#1163
20120142007
2012-06-07

Stable compositions for nucleic acid amplification and sequencing

#1164
20120141590
2012-06-07

Technology for the Preparation of Microparticles

#1165
20120141507
2012-06-07

Targeting of glycoprotein therapeutics

#1166
20120141449
2012-06-07

Albumin fusion proteins

#1167
20120141415
2012-06-07

Albumin Fusion Proteins

#1168
20120129238
2012-05-24

Reverse transcriptase mixtures with improved storage stability

#1169
20120115129
2012-05-10

Enzyme substrate comprising a functional dye and associated technology and methods

#1170
20120100597
2012-04-26

Stabilized protease-containing solutions for purifying RNA-free DNA

#1171
20120100593
2012-04-26

Crystals of membrane proteins

#1172
20120100522
2012-04-26

STABILIZED CHEMICAL DEHYDRATION OF BIOLOGICAL MATERIAL

#1173
20120100159
2012-04-26

Anti-TAT226 antibodies and immunoconjugates

#1174
20120100121
2012-04-26

Pegylated L-Asparaginase

#1175
20120093866
2012-04-19

Formulation for stabilizing proteins, which is free of mammalian excipient

#1176
20120071359
2012-03-22

Purified extended polymerase/template complex for sequencing

#1177
20120064588
2012-03-15

Protein complex having activity catalyzing asymmetric oxidation reaction and process for producing the same

#1178
20120064536
2012-03-15

Dried and stabilized ready-to-use composition containing nucleic acid polymerization enzymes for molecular biology applications

#1179
20120058098
2012-03-08

Non-cytotoxic protein conjugates

#1180
20120039801
2012-02-16

SPARC binding peptides and uses thereof

#1181
20120014954
2012-01-19

SPARC binding ScFvs

#1182
20120009646
2012-01-12

Chemically modified carbonic anhydrases useful in carbon capture systems

#1183
20120007022
2012-01-12

Control of Cyanate in Aqueous Urea Solutions by non-1,2-Ethylene Diamine like Compounds for the Protection of Protein/Peptide Carbamylation

#1184
20120003714
2012-01-05

BLENDS CONTAINING PROTEASES

#1185
20110318306
2011-12-29

Modular method to prepare tetrameric cytokines with improved pharmacokinetics by the dock-and-lock (DNL) technology

#1186
20110311487
2011-12-22

DELIVERY OF THERAPEUTIC AGENTS TO THE BONE

#1187
20110306105
2011-12-15

Engineering of yeast for cellulosic ethanol production

#1188
20110301071
2011-12-08

Stabilized Liquid Enzyme Composition

#1189
20110300623
2011-12-08

Process for accelerated capture of carbon dioxide

#1190
20110300585
2011-12-08

Systems and methods for altering rates of enzymatic processes

#1191
20110294747
2011-12-01

PEGylated mutated toxin

#1192
20110287509
2011-11-24

Stable biocatalysts of penicillin acylase as gel aggregates and the process of manufacture thereof

#1193
20110287466
2011-11-24

Method for purifying urate oxidase tetramers and octamers

#1194
20110287041
2011-11-24

Aldehyde tags, uses thereof in site-specific protein modification

#1195
20110281776
2011-11-17

Integrated sample preparation systems and stabilized enzyme mixtures

#1196
20110280830
2011-11-17

Albumin Fusion Proteins

#1197
20110274704
2011-11-10

Compositions and methods of use of immunotoxins comprising ranpirnase (Rap) show potent cytotoxic activity

#1198
20110269244
2011-11-03

LIGAND-DIRECTED COVALENT MODIFICATION OF PROTEIN

#1199
20110256267
2011-10-20

STABILIZATION OF ASPARAGINASE

#1200
20110251116
2011-10-13

Multiple mutation variants of serine protease